Table 1.
Patients screened at admission (T0) and during hospitalization (T1-T3), distributed in the various geographical centres, in intensive care unit (ICU) or other wards (non-ICU), over the two observational periods, assessing the prevalence of colonization due to carbapenem-resistant enterobacterales (CRE) strains.
| Centres | ICU | Non-ICU | ||||||
|---|---|---|---|---|---|---|---|---|
| Period I | Period II | Period I | Period II | |||||
| T0 | T1-T3 | T0 | T1-T3 | T0 | T1-T3 | T0 | T1-T3 | |
| Genoa Patients Positive patients |
370 16 (4.3%) |
325 21 (6.5%) |
211 7 (3.3%) |
180 3 (1.7%) |
251 19 (7.6%) |
196 12 (6.1%) |
195 10 (5.1%) |
173 3 (1.7%) |
| Turin Patients Positive patients |
1024 31 (3.0%) |
170 59 (34.7%) |
392 13 (3.3%) |
84 17 (20.2%) |
— | — | — | — |
| Bologna Patients Positive patients |
515 41 (8.0%) |
427 42 (9.8%) |
244 14 (5.7%) |
230 15 (6.5%) |
834 31 (3.7%) |
420 21 (5.0%) |
223 11 (4.9%) |
210 15 (7.1%) |
| Florence Patients Positive patients |
2157 69 (3.2%) |
438 33 (7.5%) |
402 17 (4.2%) |
90 5 (5.6%) |
325 18 (5.5%) |
165 2 (1.2%) |
74 7 (9.5%) |
47 6 (12.8%) |
| Catania Patients Positive patients |
200 5 (2.5%) |
115 12 (10.4%) |
122 54 (44.3%) |
65 2 (3.1%) |
213 3 (1.4%) |
89 3 (3.4%) |
162 70 (43.2%) |
86 8 (9.3%) |
| Naples Patients Positive patients |
168 6 (3.6%) |
78 5 (6.4%) |
164 14 (8.5%) |
62 12 (19.4%) |
494 10 (2.0%) |
171 3 (1.8%) |
421 12 (2.9%) |
125 6 (4.8%) |
| Palermo Patients Positive patients |
465 49 (10.5%) |
165 45 (27.3%) |
489 113 (23.1%) |
142 78 (54.9%) |
252 12 (4.8%) |
74 16 (21.6%) |
696 85 (12.2%) |
240 48 (20.0%) |
| Total Patients Positive patients |
4899 217 (4.4%) |
1718 217 (12.6%) |
2024 232 (11.5%) |
853 132 (15.5%) |
2369 93 (3.9%) |
1115 57 (5.1%) |
1771 195 (11.0%) | 881 86 (9.8%) |
Italy 2018–2020.